Elecsys Troponin T Gen 5 STAT assay
A laboratory blood test from Roche Diagnostics that measures cardiac troponin T in lithium heparin plasma. It is sold with its own calibrator and control materials. FDA cleared it in January 2017 (510(k) K162895). FDA's decision summary describes it as an aid in diagnosing a heart attack (myocardial infarction) and says it runs on cobas system analyzers.
- Product
- In this atlas
Overview
Technical summary
FDA 510(k) K162895, decision date 2017-01-18 (received 2016-10-17), applicant Roche Diagnostics, product code MMI, device class 2, regulation number 862.1215, traditional clearance with a summary, decision Substantially Equivalent. The clearance covers the immunoassay and three related materials: the Elecsys Troponin T Gen 5 STAT CalSet, Elecsys PreciControl Troponin and Elecsys Troponin T Gen 5 CalCheck 5. Neither the openFDA record nor the decision summary calls the assay high-sensitivity, so this page does not. The FDA summary is cite-only here. The sources read do not say who sells the assay today.
Product details
- Type
- Diagnostic
- Model or formulation
- Elecsys Troponin T Gen 5 STAT Assay, Elecsys Troponin T Gen 5 STAT CalSet, Elecsys PreciControl Troponin and Elecsys Troponin T Gen 5 CalCheck 5, as the openFDA record names the cleared set
- Version
- Original clearance K162895; later changes are not described here
Intended-use sources
-
- Locator
- Whole source
- How it applies
- Source of the stated intended use
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
Claims and evidence
Context United States 510(k) clearance K162895 for a Roche cardiac troponin T blood test
- Recipient
- Recipient not specified
- Population
- Samples of lithium heparin plasma tested for cardiac troponin T on cobas system analyzers, to help diagnose a myocardial infarction (restated from the FDA decision summary). For prescription use and in vitro diagnostic use; results are to be used together with clinical signs and symptoms.
- Care setting
- Laboratory testing (the test runs on cobas system analyzers).
- Geography
- United States (decision by the US Food and Drug Administration).
- Life stage
- Not stated in the FDA record.
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (regulatory decision).
Eligibility: 3 inclusion criteria; exclusion criteria not stated
- Included
- Lithium heparin plasma samples
- Use to help diagnose a myocardial infarction
- Prescription use and in vitro diagnostic use
- Excluded
- None stated
The US Food and Drug Administration cleared 510(k) premarket notification K162895 on 18 January 2017, after receiving it on 17 October 2016. The openFDA record names Roche Diagnostics as applicant, lists the Elecsys Troponin T Gen 5 STAT Assay together with its CalSet, PreciControl Troponin and CalCheck 5 materials, and gives product code MMI, device class 2, regulation number 862.1215, a traditional clearance with a summary, and the decision Substantially Equivalent (code SESE). FDA's decision summary describes the immunoassay as a quantitative measurement of troponin T from the heart, made on lithium heparin plasma, that is meant to help diagnose myocardial infarction, for use on cobas system analyzers. Its special conditions for use are prescription use and in vitro diagnostic use. It adds that troponin readings must be read alongside the patient's signs and symptoms. It gives claimed cut-offs taken from the upper 99th-percentile reference value in apparently healthy adults: 19 ng/L for all, 22 ng/L for men and 14 ng/L for women.
Applies to Recipient not specified- Samples of lithium heparin plasma tested for cardiac troponin T on cobas system analyzers, to help diagnose a myocardial infarction (restated from the FDA decision summary). For prescription use and in vitro diagnostic use; results are to be used together with clinical signs and symptoms.
- Laboratory testing (the test runs on cobas system analyzers).
- United States (decision by the US Food and Drug Administration).
- Not stated in the FDA record.
- Gestational age Not reported
- Postnatal age Not reported
- Certainty method
- Not assessed
- Limitations
- The decision summary and the openFDA record do not call the assay high-sensitivity, so this page does not. The summary says that in women a positive result is less often a true heart attack at 14 ng/L, the threshold set for women, than at 19 ng/L, and that, at the lower end of the 95% interval, as many as 69%, 82% and 78% of the positive results in women are not myocardial infarction (the summary does not say here which results those three figures describe). It sets what the test is for; it is not evidence of how well the test performs in a given patient. The calibrator and control materials in the same clearance are not described. The FDA summary is cite-only here, so its wording is restated and not quoted. openFDA data are unvalidated.
- Last checked
- 2026-10-15
- Next evidence check due
- Not scheduled
Sources and citations (26)
-
- Locator
- results[0].k_number
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].device_name
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].applicant
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].product_code
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].decision_date
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].decision_code
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].decision_description
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].date_received
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].clearance_type
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].statement_or_summary
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].advisory_committee_description
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].openfda.regulation_number
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].openfda.device_class
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].openfda.medical_specialty_description
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- results[0].openfda.device_name
- How it applies
- openFDA record field.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- meta.last_updated
- How it applies
- Statement in the cited record.
- Retrieved
- Source effective date
- 2026-10-05
- Source state
- Current
- Snapshot hash
51d3e676c79a63c9b7d7501c1632f1735ec5e6ad6be7b41673571337d1a131ee- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-15 as ck-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/ck-openfda-510k-k162895.json. It includes a contact name and address that FDA publishes; records here do not repeat them.
-
- Locator
- Decision summary, H.2 Indication(s) for use
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.2 Indication(s) for use (quote 2)
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.2 Indication(s) for use (quote 3)
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, C. Measurand
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.3 Special conditions for use
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.3 Special conditions for use (quote 2)
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.3 Special conditions for use (quote 3)
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.3 Special conditions for use (quote 4)
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, H.3 Special conditions for use (quote 5)
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
-
- Locator
- Decision summary, M.4 Clinical cut-off
- How it applies
- FDA decision summary.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
8df8742bb9508cf0c6d4dbc03562fa03dc268b9f9070dd8a74731c0ee607468a- Reuse basis
- FDA document fetched 2026-10-15 from accessdata.fda.gov. FDA's own website reuse terms were not read for this atlas, so public text is cite_only until they are. Hash only; the PDF is not committed (fetched as ck-fda-k162895-summary.pdf).
Authorization
Regulatory decision: Elecsys Troponin T Gen 5 STAT assay
- Samples of lithium heparin plasma tested for cardiac troponin T on cobas system analyzers, to help diagnose a myocardial infarction (restated from the FDA decision summary). For prescription use and in vitro diagnostic use; results are to be used together with clinical signs and symptoms.
- Laboratory testing (the test runs on cobas system analyzers).
- United States (decision by the US Food and Drug Administration).
- Not stated in the FDA record.
- Gestational age Not reported
- Postnatal age Not reported
- Authority
- U.S. Food and Drug Administration
- Decision
- Clearance,
- Pathway
- 510(k)
- Submission
K162895- Product code
MMI- Device class
- Class II
- Jurisdictions
- United States; note: United States
- Product version
- Elecsys Troponin T Gen 5 STAT Assay, with its CalSet, PreciControl Troponin and CalCheck 5 materials, as cleared in K162895
- Indication
- Quantitative measurement of cardiac troponin T in lithium heparin plasma, meant to help diagnose myocardial infarction, for use on cobas system analyzers; for prescription use and for in vitro diagnostic use; results are to be read alongside clinical signs and symptoms; in women a positive result is less often a true heart attack at the 14 ng/L cut-off than at 19 ng/L (FDA decision summary, restated).
- Basis
- The US Food and Drug Administration cleared 510(k) premarket notification K162895 on 18 January 2017, after receiving it on 17 October 2016. The openFDA record names Roche Diagnostics as applicant, lists the Elecsys Troponin T Gen 5 STAT Assay together with its CalSet, PreciControl Troponin and CalCheck 5 materials, and gives product code MMI, device class 2, regulation number 862.1215, a traditional clearance with a summary, and the decision Substantially Equivalent (code SESE). FDA's decision summary describes the immunoassay as a quantitative measurement of troponin T from the heart, made on lithium heparin plasma, that is meant to help diagnose myocardial infarction, for use on cobas system analyzers. Its special conditions for use are prescription use and in vitro diagnostic use. It adds that troponin readings must be read alongside the patient's signs and symptoms. It gives claimed cut-offs taken from the upper 99th-percentile reference value in apparently healthy adults: 19 ng/L for all, 22 ng/L for men and 14 ng/L for women.
Limitations. The decision summary and the openFDA record do not call the assay high-sensitivity, so this page does not. The summary says that in women a positive result is less often a true heart attack at 14 ng/L, the threshold set for women, than at 19 ng/L, and that, at the lower end of the 95% interval, as many as 69%, 82% and 78% of the positive results in women are not myocardial infarction (the summary does not say here which results those three figures describe). It sets what the test is for; it is not evidence of how well the test performs in a given patient. The calibrator and control materials in the same clearance are not described. The FDA summary is cite-only here, so its wording is restated and not quoted. openFDA data are unvalidated.
Record details
- Record id
cardio:elecsys-troponin-t-gen5- Content hash
2b5d2ef1ea4f7a1c55e2321245217133452522dcfe8dea7c4ccaedea9aa6edff